| Unadjusted | PS matched | PS weighted | ||||||
---|---|---|---|---|---|---|---|---|---|
Erythromycin (n = 235) | Controls (n = 470) | P value | Erythromycin (n = 211) | Controls (n = 211) | P value | Erythromycin | Controls | P value | |
30-day mortality | 60 (25.9) | 117 (25.4) | 0.93 | 54 (26.0) | 56 (27.3) | 0.91 | 27.7 | 25.9 | 0.67 |
 ICU length of stay, days | 8 [5, 14] | 7 [4, 11] | < 0.001 | 8 [5, 13] | 8 [5, 13] | 0.51 | 7 [5, 13] | 7 [4, 11] | 0.06 |
 Hospital length of stay, days | 23 [13, 40] | 19 [11, 36] | 0.031 | 22 [12, 37.5] | 21 [12, 39] | 0.61 | 21 [10, 37] | 20 [11, 37] | 0.69 |
 Duration of mechanical ventilation, days* | 6 [4, 11] | 5 [3, 9] | 0.001 | 6 [4, 11] | 6 [3, 10] | 0.48 | 6 [4, 10] | 5 [3, 9] | 0.11 |
 ΔSOFA day 4†| −1.5 (2.9) | −1.2 (2.6) | 0.35 | −1.5 (2.9) | −1.6 (2.7) | 0.79 | −1.3 (2.8) | −1.4 (2.7) | 0.75 |
 Incidence of ICU-acquired infections | 42 (17.9) | 51 (10.9) | 0.013 | 35 (16.6) | 32 (15.2) | 0.79 | 13.8 | 12.0 | 0.51 |
 Incidence of ICU-acquired AKI | 17 (7.2) | 24 (5.1) | 0.31 | 16 (7.6) | 15 (7.1) | > 0.99 | 6.4 | 5.5 | 0.66 |
 Incidence of ICU-acquired ARDS | 9 (3.8) | 19 (4.0) | > 0.99 | 8 (3.8) | 13 (6.2) | 0.38 | 3.3 | 4.6 | 0.43 |